Cita APA

Quintela-Fandino, M., Holgado, E., Manso, L., Cortés Castan, J., Morales, S., Bermejo, B., & Colomer, R. (2020). Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: A pilot clinical trial.

Citación estilo Chicago

Quintela-Fandino, Miguel, Esther Holgado, Luis Manso, Javier Cortés Castan, Serafin Morales, Begoña Bermejo, y Ramon Colomer. Immuno-priming Durvalumab With Bevacizumab in HER2-negative Advanced Breast Cancer: A Pilot Clinical Trial. 2020.

Cita MLA

Quintela-Fandino, Miguel, et al. Immuno-priming Durvalumab With Bevacizumab in HER2-negative Advanced Breast Cancer: A Pilot Clinical Trial. 2020.